Liquidity Agreement and Total Voting Rights
01/11/2021
RNS
Results of annual general meeting
19/10/2021
Total Voting Rights
01/10/2021
R&D update
30/09/2021
Notice of AGM
29/09/2021
Notice of rescheduled AGM
Half year 2021 results
27/09/2021
Proposed accounting treatment of DHSC dispute
16/09/2021
AGM voting
13/09/2021
01/09/2021
20/08/2021
Half Year Update
18/08/2021
Notice of investor meeting
05/08/2021
02/08/2021
David Allmond to be CEO, Graham Mullis to retire
29/07/2021
Director/PDMR Shareholding
06/07/2021
01/07/2021
Publication of Annual Report
29/06/2021
Expansion of PathFlow COVID-19 LFT portfolio
Full year 2020 results and update on strategy
22/06/2021
For Investor Relations Support for the Novacyt Group, please click the button below to contact our team.
